Wikidata

(Q61980939)

English

Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia

clinical trial

In more languages

Statements

title
A Phase II Study to Determine the Safety, Efficacy, and Pharmacokinetics of Multiple Intravenous Doses of ALD518 80 mg, 160 mg, and 320 mg Versus Placebo Administered to Patients With Non-Small Cell Lung Cancer-Related Fatigue and Cachexia (English)
0 references
medical condition
fatigue
0 references
country
Australia
0 references
Canada
0 references
Georgia
0 references
India
0 references
New Zealand
0 references
Poland
0 references
Romania
0 references
Serbia
0 references
start time
September 2008
0 references
end time
August 2009
0 references
number of participants
124
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61980939&oldid=2098452299"